NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT06638931 2025-05-28ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Active not recruiting28 enrolled
NCT04280081 2025-04-20LIBRETTO-321Eli Lilly and CompanyPhase 2 Active not recruiting77 enrolled 13 charts
NCT00896454 2018-10-17Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum CalciumAmgenPhase 2 Completed33 enrolled 22 charts
NCT00019331 2013-06-20Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsNational Cancer Institute (NCI)Phase 2 Completed